What USDOJ and SEC Now Expect from Pharmaceutical, Biotechnology, Medical Device Companies, and CRO's

Event Date(s): 04/27/2015

Mr. Peterson is a panelist for “What USDOJ and SEC Now Expect from Pharmaceutical, Biotechnology, Medical Device Companies, and CROs,” at the American Conference Institute, FCPA and Anti-Corruption for the Life Sciences Industry.  U.S. and international enforcement authorities have continued their vigorous pursuit of life sciences companies for FCPA and anti-corruption violations, resulting in recent high profile investigations across the globe and heightened government compliance expectations.

In response to this daunting climate, ACI’s 10th Advanced Conference on FCPA & Anti-Corruption for the Life Sciences Industry provides a forum for the key players - top federal prosecutors, preeminent corporate counsel, and leading FCPA practitioners - to come together for critical networking and benchmarking on how to combat the next wave of global anti-corruption risk factors confronting the industry.

Event Link: http://fcpaconference.com/pharma/